Ganglioside GM1 activates the mitogen-activated protein kinase Erk2 and p70 S6 kinase in U-1242 MG human glioma cells

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 116-125

  Van Brocklyn, James R ^a   Vandenheede, J R ^b   Fertel, Richard ^a   Yates, Allan J ^a   Rampersaud, Arfaan A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Erk2; Gangliosides; Gliomas; Mitogen activated protein kinase; p70 S6 kinase

Indexed keywords

GANGLIOSIDE GM1; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031006192     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010116.x     Document Type: Article

References (52)

1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., and Saltiel A. R. (1995) PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Augé N., Andrieu N., Nère-Salvayre A., Thiers J. C., Levade T., and Salvayre R. (1996) The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271, 19251-19255.
3. 35S] sulfate into brain constituents and the effects of thyroid hormone on myelination. Brain Res. 30, 273-293.
4. Berra B., Gaini S. M., and Riboni L. (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int. J. Cancer 36, 363-366.
5. Bremer E. G., Hakomori S.-i., Bowen-Pope D. F., Raines E., and Ross R. (1984) Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J. Biol. Chem. 259, 6818-6825.
6. Bremer E. G., Schlessinger J., and Hakomori S.-i. (1986) Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261, 2434-2440.
7. Byrne M. C., Farooq M., Sbaschnig-Agler M., Norton W. T., and Ledeen R. W. (1988) Ganglioside content of astroglia and neurons isolated from maturing rat brain: consideration of the source of astroglial gangliosides. Brain Res. 461, 87-97.
8. Crews C. M. and Erikson R. L. (1993) Extracellular signals and reversible protein phosphorylation: what to MEK of it all. Cell 74, 215-217.
9. Davis R. J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556.
10. Dudley D. T., Pang L., Decker S. J., Bridges A. J., and Saltiel A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.
11. s6k. Crit. Rev. Biochem. Mol. Biol. 29, 385-413.
12. Gieselmann V. (1995) Lysosomal storage diseases. Biochim. Biophys. Acta 1270, 103-136.
13. Graves L. M., Bornfeldt K. E., Raines E. W., Potts B. C., MacDonald S. G., Ross R., and Krebs E. G. (1993) Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad, Sci. USA 90, 10300-10304.
14. Hakomori S.-i. (1970) Cell density-dependent changes of glycolipid concentrations in fibroblasts and loss of this response in virus transformed cells. Proc. Natl. Acad. Sci. USA 67, 1741-1747.
15. Jeffries H. B. J., Thomas G., and Thomas G. (1994) Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA 91, 4441-4445.
16. Kaufmann B., Basu S., and Roseman S. (1967) Studies on the biosynthesis of gangliosides, in Inborn Disorders of Sphingolipid Metabolism (Anderson S. M. and Volk B. W., eds), pp. 193-213. Pergamon Press, New York.
17. Kolesnick R. and Golde D. W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77, 325-328.
18. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
19. Ledeen R. W. (1989) Biosynthesis, metabolism and biological effects of gangliosides, in Neurobiology of Glycoconjugates (Margolis R. U. and Margolis R. K., eds), pp. 43-83. Plenum Press, New York.
20. Liepkalns V. A., Icard C., Yates A. J., Thompson D. K., and Hart R. W. (1981) Effects of cell density on lipids of human glioma and fetal neural cells. J. Neurochem. 36, 1959-1965.
21. Mahuran D. J. (1991) The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. Biochim. Biophvs. Acta 1096, 87-94.
22. Mansour S. J., Matten W. T., Hermann A. S., Candia J. M., Rong S., Fukasawa K., Vande Woude G. F., and Ahn N. G. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-969.
23. Miettien T. and Takki-Luukkainen I. T. (1959) Use of butyl acetate in determination of sialic acid. Acta Chem. Scand. 13, 856-885.
24. ras. Nature 371, 426.
25. Nishida E. and Gotoh Y. (1993) The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18, 128-131.
26. Obeid L. M. and Hannun Y. A. (1995) Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 58, 191-198.
27. Olivera A., Buckley N. E., and Spiegel S. (1992) Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. 267, 26121-26127.
28. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90, 8319-8323.
29. Pelech S. J. (1993) Networking with protein kinases. Curr. Biol. 3, 513-515.
30. Pettman B., Manthorpe M., and Varon S. (1988) Ganglioside GM1 actions on cell-substratum adhesion and DNA synthesis by cultured astroglial cells. J. Neurosci. Res. 20, 442-450.
31. Raines M. A., Kolesnick R. N., and Golde D. W. (1993) Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268, 14572-14575.
32. Saqr H. E., Lee M.-C., Burkman A. M., and Yates A. J. (1995a) Gangliosides have a bimodal effect on DNA synthesis in U-1242 MG human glioma cells. J. Neurosci. Res. 41, 491-500.
33. Saqr H. E., Walters J. D., Guan Z., Stokes B. T., and Yates A. J. (1995b) Gangliosides inhibit PDGF-induced signal transduction events in U-1242 MG human glioma cells. Neurochem. Res. 20, 1389-1395.
34. Sevetson B. R., Kong X., and Lawrence J. C. Jr. (1993) Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 90, 10305-10309.
35. Spiegel S. and Fishman P. H. (1987) Gangliosides as bimodal regulators of cell growth. Proc. Natl. Acad. Sci. USA 84, 141-145.
36. Stults C. L. M., Sweeley C, C., and Macher B. A. (1989) Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 179, 167-214.
37. Sung C.-C., Pearl D. K., Coons S. W., Scheithauer B. W., Johnson P. C., and Yates A. J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 74, 3010-3022.
38. Sung C.-C., Pearl D. K., Coons S. W., Scheithauer B. W., Johnson P. C., Zheng M., and Yates A. J. (1995) Correlation of ganglioside patterns of primary brain tumors with survival. Cancer 75, 851-859.
39. Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloride acid method. Biochim. Biophys. Acta 24, 604-611.
40. Takamiya K., Yamamoto A., Furukawa K., Yamashiro S., Shin M., Okada M., Fukumoto S., Haraguchi M., Takeda N., Fujimura K., Sakae M., Kishikawa M., Shiku H., Furukawa K., and Aizawa S. (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 93, 10662-10667.
41. Traylor T. D. and Hogan E. L. (1980) Gangliosides of human cerebral astrocytomas. J. Neurochem. 34, 126-131.
42. Tybulewicz V. L. J., Tremblay M. L., LaMarca M. E., Willemsen R., Stubblefield B. K., Winfield S., Zablocka B., Sidransky E., Martin B. M., Huang S. P., Mintzer K. A., Westphal H., Mulligan R. C., and Ginns E. I. (1992) Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357, 407-410.
43. Van Brooklyn J., Bremer E. G., and Yates A. J. (1993) Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242 MG and Swiss 3T3 cells. J. Neurochem. 61, 371-374.
44. van Echten G. and Sandhoff K. (1993) Ganglioside metabolism. Enzymology, topology and regulation. J. Biol. Chem. 268, 5341-5344.
45. Wu J., Dent P., Jelinek T., Wolfman A., Weber M. J., and Sturgill T. W. (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262, 1065-1069.
46. Yamanaka S., Johnson M. D., Grinberg A., Westphal H., Crawley J. N., Taniike M., Suzuki K., and Proia R. L. (1994) Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA 91, 9975-9979.
47. Yates A. J. (1986) Gangliosides in the nervous system during development and regeneration. Neurochem. Pathol. 5, 309-329.
48. Yates A. J. (1988) Glycolipids and gliomas. Neurochem. Pathol. 8, 157-180.
49. Yates A. J., Thompson D. K., Boesel C. P., Albrightson C., and Hart R. W. (1979) Lipid composition of human neural tumors. J. Lipid Res. 20, 428-436.
50. Yates A. J., Walters J. D., Wood C. L., and Johnson J. D. (1989) Ganglioside modulation of cyclic AMP-dependent protein kinase and cyclic nucleotide phosphodiesterase in vitro. J. Neurochem. 53, 162-167.
51. Yates A. J., Agudelo J. D., and Sung C.-C. (1992) Glycolipids of a human glioma cell line bearing receptors for platelet-derived growth factor (PDGF). Lipids 27, 308-310.
52. Yates A. J., Van Brocklyn J., Saqr H. E., Guan Z., Stokes B. T., and O'Dorisio M. S. (1993) Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding. Exp. Cell Res. 204, 38-45.